|Application ||WB, E|
|Other Accession||Q8CG07, Q91XU0, NP_064520.2|
|Calculated MW||72133 Da|
|Antigen Region||1-30 aa|
|Other Names||ATPase WRNIP1, Werner helicase-interacting protein 1, WRNIP1 (HGNC:20876)|
|Target/Specificity||This WRNIP1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human WRNIP1.|
|Precautions||WRNIP1 Antibody (N-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Functions as a modulator of initiation or reinitiation events during DNA polymerase delta-mediated DNA synthesis. In the presence of ATP, stimulation of DNA polymerase delta-mediated DNA synthesis is decreased.|
|Cellular Location||Nucleus. Note=Colocalizes with WRN in granular structures in the nucleus.|
|Tissue Location||Ubiquitously expressed.|
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Werner's syndrome is a rare autosomal recessive disorder characterized by premature aging. The protein encoded by this gene interacts with the N-terminal portion of Werner protein containing the exonuclease domain. This protein shows homology to replication factor C family proteins, and is conserved from E. coli to human. Studies in yeast suggest that this gene may influence the aging process. Two transcript variants encoding different isoforms have been isolated for this gene.
Kaur, S., et al. Cell Cycle 9(15):3106-3111(2010)
Yoshimura, A., et al. Genes Genet. Syst. 84(2):171-178(2009)
Crosetto, N., et al. J. Biol. Chem. 283(50):35173-35185(2008)
Mano, Y., et al. Cancer Sci. 98(12):1902-1913(2007)
Bish, R.A., et al. J. Biol. Chem. 282(32):23184-23193(2007)
If you have any additional inquiries please email technical services at firstname.lastname@example.org.